340 related articles for article (PubMed ID: 30930513)
1. CRISPR: a new principle of genome engineering linked to conceptual shifts in evolutionary biology.
Koonin EV
Biol Philos; 2019; 34(1):9. PubMed ID: 30930513
[TBL] [Abstract][Full Text] [Related]
2. Origins and evolution of CRISPR-Cas systems.
Koonin EV; Makarova KS
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180087. PubMed ID: 30905284
[TBL] [Abstract][Full Text] [Related]
3. Phylogenomics of Cas4 family nucleases.
Hudaiberdiev S; Shmakov S; Wolf YI; Terns MP; Makarova KS; Koonin EV
BMC Evol Biol; 2017 Nov; 17(1):232. PubMed ID: 29179671
[TBL] [Abstract][Full Text] [Related]
4. Evolutionary Genomics of Defense Systems in Archaea and Bacteria.
Koonin EV; Makarova KS; Wolf YI
Annu Rev Microbiol; 2017 Sep; 71():233-261. PubMed ID: 28657885
[TBL] [Abstract][Full Text] [Related]
5. Live virus-free or die: coupling of antivirus immunity and programmed suicide or dormancy in prokaryotes.
Makarova KS; Anantharaman V; Aravind L; Koonin EV
Biol Direct; 2012 Nov; 7():40. PubMed ID: 23151069
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics Identification of Anti-CRISPR Loci by Using Homology, Guilt-by-Association, and CRISPR Self-Targeting Spacer Approaches.
Yin Y; Yang B; Entwistle S
mSystems; 2019 Sep; 4(5):. PubMed ID: 31506266
[TBL] [Abstract][Full Text] [Related]
7. Pseudo-chaotic oscillations in CRISPR-virus coevolution predicted by bifurcation analysis.
Berezovskaya FS; Wolf YI; Koonin EV; Karev GP
Biol Direct; 2014 Jul; 9():13. PubMed ID: 24986220
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas: Complex Functional Networks and Multiple Roles beyond Adaptive Immunity.
Faure G; Makarova KS; Koonin EV
J Mol Biol; 2019 Jan; 431(1):3-20. PubMed ID: 30193985
[TBL] [Abstract][Full Text] [Related]
9. Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms.
Koonin EV; Wolf YI
Biol Direct; 2016 Feb; 11(1):9. PubMed ID: 26912144
[TBL] [Abstract][Full Text] [Related]
10. The CRISPR-Cas system - from bacterial immunity to genome engineering.
Czarnek M; Bereta J
Postepy Hig Med Dosw (Online); 2016 Sep; 70(0):901-16. PubMed ID: 27594566
[TBL] [Abstract][Full Text] [Related]
11. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems.
Hwang S; Maxwell KL
CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas systems and RNA-guided interference.
Barrangou R
Wiley Interdiscip Rev RNA; 2013; 4(3):267-78. PubMed ID: 23520078
[TBL] [Abstract][Full Text] [Related]
13. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas and Restriction-Modification Act Additively against Conjugative Antibiotic Resistance Plasmid Transfer in Enterococcus faecalis.
Price VJ; Huo W; Sharifi A; Palmer KL
mSphere; 2016; 1(3):. PubMed ID: 27303749
[TBL] [Abstract][Full Text] [Related]
15. Regulation of CRISPR-Cas adaptive immune systems.
Patterson AG; Yevstigneyeva MS; Fineran PC
Curr Opin Microbiol; 2017 Jun; 37():1-7. PubMed ID: 28359988
[TBL] [Abstract][Full Text] [Related]
16. The CRISPR Spacer Space Is Dominated by Sequences from Species-Specific Mobilomes.
Shmakov SA; Sitnik V; Makarova KS; Wolf YI; Severinov KV; Koonin EV
mBio; 2017 Sep; 8(5):. PubMed ID: 28928211
[TBL] [Abstract][Full Text] [Related]
17. Structural biology of CRISPR-Cas immunity and genome editing enzymes.
Wang JY; Pausch P; Doudna JA
Nat Rev Microbiol; 2022 Nov; 20(11):641-656. PubMed ID: 35562427
[TBL] [Abstract][Full Text] [Related]
18. [Why so rare if so essentiel: the determinants of the sparse distribution of CRISPR-Cas systems in bacterial genomes].
Bernheim A
Biol Aujourdhui; 2017; 211(4):255-264. PubMed ID: 29956652
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas: from adaptive immune system in prokaryotes to therapeutic weapon against immune-related diseases.
Garcia-Robledo JE; Barrera MC; Tobón GJ
Int Rev Immunol; 2020; 39(1):11-20. PubMed ID: 31625429
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of CRISPR-Cas systems by mobile genetic elements.
Sontheimer EJ; Davidson AR
Curr Opin Microbiol; 2017 Jun; 37():120-127. PubMed ID: 28668720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
